Cancer group loses landmark case against gene patent

A CANCER group which fought against the patenting of the BRCA1 gene has lost its landmark case in the Federal Court but may appeal the decision.

A community just for doctors

To continue reading please login or sign up for access.

Start Today


Niamh Mullen

Niamh Mullen is a medical writer and former news director of MO.


External Contributor

Leading doctors frequently use Medical Observer to contribute to important discussions.